Blood and Blood Components Market Share & Forecast Report, 2026-2035

Blood and Blood Components Market – By Product, By Application, By End Use – Global Forecast, 2026 – 2035

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology and Scope

1.1&nbsp;&nbsp;&nbsp; Market scope and definition

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Data mining sources

1.3.1&nbsp;&nbsp;&nbsp; Global

1.3.2&nbsp;&nbsp;&nbsp; Regional/country

1.4&nbsp;&nbsp;&nbsp; Base estimates and calculations

1.4.1&nbsp;&nbsp;&nbsp; Base year calculation

1.4.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.6&nbsp;&nbsp;&nbsp; Forecast model

1.7&nbsp;&nbsp;&nbsp; Research assumptions and limitations

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 360&deg; synopsis

2.2&nbsp;&nbsp;&nbsp; Key market trends

2.2.1&nbsp;&nbsp;&nbsp; Regional trends

2.2.2&nbsp;&nbsp;&nbsp; Product trends

2.2.3&nbsp;&nbsp;&nbsp; Application trends

2.2.4&nbsp;&nbsp;&nbsp; End use trends

2.3&nbsp;&nbsp;&nbsp; CXO perspectives: Strategic imperatives

2.3.1&nbsp;&nbsp;&nbsp; Key decision points for industry executives

2.3.2&nbsp;&nbsp;&nbsp; Critical success factors for market players

2.4&nbsp;&nbsp;&nbsp; Future outlook and strategic recommendations

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Increasing volume of surgeries globally

3.2.1.2&nbsp;&nbsp;&nbsp; Rising number of people suffering from chronic conditions including cancer

3.2.1.3&nbsp;&nbsp;&nbsp; Growing popularity of plasma therapy to treat various sport injuries, cosmetic as well as orthopedic procedures

3.2.1.4&nbsp;&nbsp;&nbsp; Several blood donation campaigns undertaken by various blood organizations

3.2.2&nbsp;&nbsp;&nbsp; Industry Pitfalls and Challenges:

3.2.2.1&nbsp;&nbsp;&nbsp; Short shelf life of blood components

3.2.2.2&nbsp;&nbsp;&nbsp; Transfusion transmitted infection (TTI) related to donated blood

3.2.3&nbsp;&nbsp;&nbsp; Market Opportunities

3.2.3.1&nbsp;&nbsp;&nbsp; Growth in personalized and targeted therapies

3.2.3.2&nbsp;&nbsp;&nbsp; Integration of digital solutions

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5&nbsp;&nbsp;&nbsp; Technological advancements

3.5.1&nbsp;&nbsp;&nbsp; Current technological trends

3.5.2&nbsp;&nbsp;&nbsp; Emerging technologies

3.6&nbsp;&nbsp;&nbsp; Supply chain analysis

3.7&nbsp;&nbsp;&nbsp; Future market trends

3.8&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.9&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2025

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis

4.3&nbsp;&nbsp;&nbsp; Company matrix analysis

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Key developments

4.6.1&nbsp;&nbsp;&nbsp; Mergers and acquisitions

4.6.2&nbsp;&nbsp;&nbsp; Partnerships and collaborations

4.6.3&nbsp;&nbsp;&nbsp; New product launches

4.6.4&nbsp;&nbsp;&nbsp; Expansion plans

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product, 2022 &mdash; 2035 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Whole blood

5.3&nbsp;&nbsp;&nbsp; Blood components

5.3.1&nbsp;&nbsp;&nbsp; Red blood cells

5.3.2&nbsp;&nbsp;&nbsp; Platelets

5.3.3&nbsp;&nbsp;&nbsp; Plasma

5.3.4&nbsp;&nbsp;&nbsp; White blood cells

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Application, 2022 &mdash; 2035 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Trauma and Surgery

6.3&nbsp;&nbsp;&nbsp; Blood disorders

6.3.1&nbsp;&nbsp;&nbsp; Anaemia

6.3.2&nbsp;&nbsp;&nbsp; Bleeding disorders

6.3.2.1&nbsp;&nbsp;&nbsp; Hemophilia

6.3.2.2&nbsp;&nbsp;&nbsp; Von willebrand disease

6.3.3&nbsp;&nbsp;&nbsp; Other blood disorders

6.4&nbsp;&nbsp;&nbsp; Cancer treatment

6.5&nbsp;&nbsp;&nbsp; Other applications

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End Use, 2022 &mdash; 2035 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Hospitals

7.3&nbsp;&nbsp;&nbsp; Ambulatory surgical centers

7.4&nbsp;&nbsp;&nbsp; Other end use

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2022 &mdash; 2035 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Spain

8.3.5&nbsp;&nbsp;&nbsp; Italy

8.3.6&nbsp;&nbsp;&nbsp; Netherlands

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; China

8.4.2&nbsp;&nbsp;&nbsp; India

8.4.3&nbsp;&nbsp;&nbsp; Japan

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; South Korea

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Argentina

8.6&nbsp;&nbsp;&nbsp; Middle East and Africa

8.6.1&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.2&nbsp;&nbsp;&nbsp; South Africa

8.6.3&nbsp;&nbsp;&nbsp; UAE

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; American Red Cross

9.2&nbsp;&nbsp;&nbsp; America&#39;s Blood Centers

9.3&nbsp;&nbsp;&nbsp; Associazione Volontari Italiani del Sangue (AVIS)

9.4&nbsp;&nbsp;&nbsp; Bloodworks Northwest

9.5&nbsp;&nbsp;&nbsp; Canada Blood Services

9.6&nbsp;&nbsp;&nbsp; Carter BloodCare

9.7&nbsp;&nbsp;&nbsp; ImpactLife

9.8&nbsp;&nbsp;&nbsp; Indian Red Cross Society

9.9&nbsp;&nbsp;&nbsp; NHS Blood and Transplant (NHSBT)

9.10&nbsp;&nbsp;&nbsp; Northern Ireland Blood Transfusion Service

9.11&nbsp;&nbsp;&nbsp; OneBlood

9.12&nbsp;&nbsp;&nbsp; Scottish National Blood Transfusion Service (NHS National Services Scotland)

9.13&nbsp;&nbsp;&nbsp; Versiti

9.14&nbsp;&nbsp;&nbsp; Vitalant

9.15&nbsp;&nbsp;&nbsp; Welsh blood service

Blood and Blood Components Market

Inquiry Before Buying